K

Kailera Therapeutics

Clinical-stage obesity and metabolic drugs developer

Manager – Patient Retention

Clinical Research OperationsUpdated on Nov 11
Full-time

About the Job

Requirements

  • Have 3–5 years of progressive clinical research experience in biotech, pharma, or a major contract research organization, such as experience as a clinical research associate, lead study coordinator, or clinical operations project manager.
  • Have advanced proficiency with electronic data capture, interactive response technology, and electronic clinical outcome assessment dashboard environments.
  • Be able to synthesize complex operational metrics and patient data trends into actionable risk-mitigation workflows.
  • Have experience navigating high-stakes conversations with principal investigators, coordinators, and external vendors.
  • Be able to self-direct and execute precisely in a fast-paced, fluid startup environment.
  • Have the emotional intelligence and solutions-oriented approach to counsel clinical teams on patient logistics and retention challenges.
  • Have a bachelor's degree in a life science discipline or healthcare administration, or equivalent practical clinical research experience.

Responsibilities

  • Monitor and analyze electronic clinical outcome assessment data portals, weekly compliance logs, and interactive response technology alerts daily to identify participant non-compliance or potential withdrawal early.
  • Develop and execute proactive, study-wide retention strategies and site-facing communication frameworks to mitigate visit fatigue and protocol discontinuations.
  • Coordinate joint company and contract research organization site outreach with operational leads to provide targeted support to struggling or high-risk clinical sites.
  • Maintain and optimize the internal clinical trial retention tracker to provide leadership and medical monitors with immediate, real-time visibility into active retention risks and resolution.
  • Design and distribute site tools, patient counseling cheat sheets, and educational resources about the non-linear nature of GLP-1 weight loss journeys.
  • Analyze participant withdrawals to identify root causes, adjust retention strategies, and clean historical electronic data capture data.

Desired Qualifications

  • Have direct operational experience working on Phase 2 or Phase 3 GLP-1, metabolic, or obesity clinical trials.
  • Have prior experience managing complex protocol work alongside large-scale tier-one contract research organizations.

About the Company

Kailera Therapeutics

Clinical-stage obesity and metabolic drugs developer

Kailera Therapeutics focuses on obesity and related metabolic conditions by acquiring and developing clinical-stage drug candidates and moving them toward commercialization. Its lead asset, KAI-9531, is an injectable dual agonist of GLP-1 and GIP receptors for obesity and type 2 diabetes, and the pipeline includes an oral GLP-1 agonist (KAI-7535), an oral tablet form of KAI-9531, and an injectable tri-agonist targeting GLP-1, GIP, and glucagon receptors (KAI-4729). The company differentiates itself by sourcing assets outside of early research, pursuing a mix of injectable and oral therapies, and leveraging a high-profile leadership team and substantial funding to progress a broad portfolio under external licenses. Kailera’s goal is to advance multiple metabolic disease therapies from clinical development toward commercialization to improve outcomes for patients with obesity and related conditions.

Company size
51-200
Company stage
IPO
Headquarters
Waltham, MA
Founded
2024

Recently Posted Jobs

Explore more opportunities at Kailera Therapeutics

See more jobs